AI in Medical Toxicology: Evidence, Uses, and Limits
Omid Mehrpour
Post on 21 Aug 2024 · Updated 15 Nov 2026 · 14 min read
Omid Mehrpour
Post on 21 Aug 2024 · Updated 15 Nov 2026 · 14 min read
https://medicaltoxic.com/blogs/ai-in-medical-toxicology-evidence-risks-limits
Artificial intelligence (AI) is increasingly being investigated in medical toxicology, from identifying possible toxic exposures to predicting complications and helping clinicians document poisoning cases.
Some results are promising. Machine-learning studies have analyzed hundreds of thousands of poison-center records, while newer large language model (LLM) studies have tested AI-generated clinical documentation against records written by physicians.
However, strong performance in a controlled study does not automatically establish that an AI system is safe or effective for independent clinical decision-making.
For example, an AI model may distinguish among a limited group of known poisons yet perform much worse when additional substances are introduced. A language model may produce a highly rated clinical note while still omitting important findings or generating a potentially harmful recommendation.
The most useful question is therefore not simply whether AI can be used in medical toxicology.
It is:
Which toxicology tasks have been directly studied, how reliable are the results, and what safeguards are needed before clinical use?
AI has been studied for toxin identification, poisoning-risk prediction, clinical documentation, research and surveillance.
A 2023 deep-learning study analyzed 201,031 single-agent poisonings and reported approximately 83% classification accuracy for selected substances.
The ToxNet study reported a micro-F1 score of approximately 0.66 when classifying 10 substances, falling to approximately 0.27 when expanded to 28 substances.
These findings do not establish that AI generally diagnoses poisoning more accurately than medical toxicologists.
A 2024 methanol study developed models predicting the need for intubation, but it did not establish that using those models improves real-world patient outcomes.
A 2026 study of 256 acute-poisoning records found promising documentation performance, alongside a higher frequency of potentially serious errors in AI-generated notes.
Most AI applications in acute poisoning remain at the development, retrospective validation or feasibility stage.
AI-generated drug doses, antidote decisions and disposition recommendations must not be accepted without appropriate clinical verification.
The safest current role for AI is to support appropriately trained professionals, not replace toxicology expertise.
Medical toxicology involves recognizing and treating harmful exposures to medications, chemicals, drugs of abuse, environmental agents and naturally occurring toxins.
Clinical decisions often depend on incomplete information.
A patient may be unable to identify the substance ingested. Several drugs may have been taken together. Symptoms may evolve over time, and routine laboratory testing may not identify every exposure.
AI research attempts to assist with some of these challenges by identifying patterns in large datasets.
Potential applications include:
Application | Intended task | Main evidence limitation |
|---|---|---|
Toxin identification | Rank possible substances from symptoms and exposure information | Performance depends on included substances and training data |
Severity prediction | Estimate risk of complications or intensive care | Retrospective discrimination does not establish clinical benefit |
Clinical documentation | Structure notes and summarize case details | Omissions, fabrications and incorrect plans remain possible |
Poison-center workflow | Organize calls, histories and case information | Product capabilities do not establish improved patient outcomes |
Surveillance | Identify unusual exposure trends | Signals require confirmation and may reflect reporting bias |
Chemical toxicity prediction | Screen experimental compounds | Preclinical toxicity prediction is not bedside poisoning diagnosis |
These applications should be evaluated separately.
An algorithm designed for preclinical chemical screening is not necessarily suitable for diagnosing an emergency department patient.
A 2023 study by Mehrpour and colleagues evaluated two deep-learning approaches for distinguishing acute poisonings.
The researchers analyzed 201,031 single-agent poisoning cases using models developed with PyTorch and Keras.
For classification among the selected substances, both approaches achieved approximately 83% accuracy.
The models performed particularly well in certain individual substance categories, including lithium and sulfonylurea poisoning. [1]
These results demonstrate that machine learning can identify patterns in structured poisoning data.
The analysis excluded polysubstance ingestions.
It also used a limited selection of toxic agents.
Consequently, the reported accuracy should not be interpreted as the expected performance of an AI system when evaluating:
an unidentified exposure;
a patient who took several substances;
a newly emerging drug;
an uncommon poisoning;
a patient whose presentation differs from the training population.
Nor does the study demonstrate that using the model improves survival, reduces treatment delays or safely replaces clinical toxicologists.
Those outcomes require separate evaluation.
ToxNet is an important example of AI-based toxin prediction using poison-center data.
In research published in Clinical Toxicology, Zellner and colleagues developed a machine-learning system using records from 781,278 poison-center calls.
The underlying cases involved single-substance intoxications.
The investigators tested the model in two stages. [2]

In the initial test involving 8,995 cases and 10 substances, ToxNet achieved a micro-F1 score of approximately 0.66.
The model outperformed several comparison algorithms and the physicians participating in the study's defined comparison tasks.
When testing expanded to 28 substances and 36,033 cases, its overall micro-F1 score fell to approximately 0.27.
The investigators still reported favorable comparisons with their selected baselines and physicians within the experimental setup.
But the substantial reduction in model performance as the classification task became broader is essential context.
The appropriate interpretation is not that ToxNet is universally superior to physicians.
It is that a model may outperform selected comparators in a restricted research environment while still making substantial classification errors.
The study authors described ToxNet as a potential future decision-support tool, with further research required.
A model's relative ranking against a comparator is not a substitute for evaluating its absolute error rate and clinical consequences.
Machine-learning models have also been investigated for predicting outcomes such as intensive care requirements, respiratory complications and mortality.
These applications differ from toxin identification.
A model may be designed to estimate whether a patient is likely to deteriorate rather than identify the chemical responsible.
A 2024 study published in Scientific Reports evaluated machine-learning and deep-learning models for predicting the need for intubation after methanol poisoning.
The investigators used 897 patient records from a single hospital in Tehran, including 202 patients who required intubation. [3]
They compared multiple algorithms and used cross-validation and explainability methods.
Some models achieved high performance on the studied dataset.
These results are useful for research into risk prediction.
However, the models were developed and assessed using retrospective records from a specific clinical setting.
The study did not demonstrate that routine clinical deployment of the models reduces mortality or improves the timing of intubation.
A model estimating a patient's risk of intubation should not independently decide that intubation is required.
The decision depends on the actual clinical assessment, airway protection, respiratory status, acid-base abnormalities and other relevant findings.
A prediction score can contribute information, but it should not replace evidence-based emergency management.
One of the most directly relevant recent studies evaluated AI-generated medical records for patients with acute poisoning.
Published in the Journal of Medical Internet Research in June 2026, the study included 256 acute-poisoning cases.
Researchers compared initial senior physician ward-round records produced by DeepSeek, ChatGPT and physicians.
Three experienced emergency physicians evaluated the records without knowing which source produced each document. [4]
The mean overall quality scores were:
Record source | Mean score, maximum 25 |
|---|---|
DeepSeek | 24.14 |
Physician-written records | 23.86 |
ChatGPT | 23.30 |
The study used the specific model versions and prompting methods available during its evaluation period.
These scores should not be extrapolated to other model versions or documentation settings.
The researchers also identified records with high potential for harm.
Such errors occurred in:
3.1% of DeepSeek-generated records;
2.0% of ChatGPT-generated records;
0.8% of physician-written records.
The AI groups had a significantly higher combined frequency of high-harm errors than the physician group. [4]
Examples included omission of critical physical findings, inappropriate care-level recommendations and problems with severity assessment.
The study was retrospective, single-center and conducted using Chinese-language documentation.
It therefore does not establish that AI-generated notes are safe for unsupervised use across hospitals, languages or poisoning types.
The clinically important distinction is:
Producing a well-written note is not the same as making a safe treatment decision.
A 2026 preliminary study in Forensic Science International tested language-model interpretation of 10 anonymized forensic toxicology cases.
The tested models correctly identified 93% of 15 substances across the cases.
However, markedly overconfident language appeared in 70% of the cases. The researchers also identified inconsistent handling of interpretive limitations. [5]
This was a small forensic study, not an emergency department trial.
Its findings nevertheless illustrate a relevant clinical risk.
An AI-generated explanation can appear confident and plausible even when it omits important uncertainty.
This is particularly concerning when interpreting:
drug concentrations;
unexpected screening results;
mixed exposures;
timing-dependent measurements;
findings that do not match the clinical presentation.
For detailed discussion of the limitations of conventional toxicology testing, see Drug Screens Lie: A Clinician’s Guide to Interpreting Toxicology Tests Safely.
A drug result or an AI interpretation should always be assessed in the context of the patient.
A September 2026 narrative review specifically examined AI applications in acute poisoning management.
The authors identified research involving:
medical history collection;
toxin recognition;
complication prediction;
prognostic assessment;
clinical decision support;
remote consultation;
public-health surveillance;
patient education.
However, they concluded that most applications remain at model-development, retrospective-validation, laboratory-testing or small-scale feasibility stages. [6]
The review emphasized the need for external validation, interpretability, multicenter evaluation, workflow integration and regulatory oversight.
Because this is a narrative review, it is useful for understanding the research landscape.
It should not override the more direct performance and safety findings of the individual human studies discussed above.
Poison centers regularly manage incomplete exposure histories and time-sensitive questions.
AI systems may potentially assist with tasks such as:
organizing call information;
transcribing conversations;
identifying missing exposure details;
suggesting relevant reference materials;
preparing draft case notes;
identifying cases requiring further review;
summarizing exposure trends.
The conventional poison-center workflow remains important.
For context on the information that specialists gather during poisoning consultations, see The Role of Poison Center Calls: Managing Poisoning Cases from Emergency Calls to Critical Decisions.
A system that helps organize a poisoning call is not necessarily validated to diagnose the exposure.
Likewise, generating a clinical note does not establish that the system can independently decide:
whether an antidote is indicated;
which dose to administer;
whether a patient requires intensive care;
when observation can safely end;
whether laboratory findings exclude poisoning.
Clinical responsibility must remain with appropriately trained professionals.
MedicalToxic develops a clinical workflow platform called ToxLumen.
According to its current product description, the platform supports structured case information, reviewable AI-generated drafts, evidence access, clinical tools, safety alerts and finalized documentation.
The platform also describes the separation of deterministic calculations from AI-generated text, with clinicians retaining responsibility for reviewing and finalizing clinical records.
Disclosure: ToxLumen is a MedicalToxic product. These descriptions come from the product's own published documentation and should not be interpreted as independent proof of diagnostic accuracy, improved outcomes or clinical validation.
A useful clinical AI system should make its limitations visible rather than imply that every generated answer has been independently verified.
The World Health Organization has published guidance on the ethics and governance of large multimodal AI models in health care. [7]
The FDA and international medical-device regulators have also published Good Machine Learning Practice principles covering safe development and evaluation of AI-enabled medical technologies. [8]
For medical toxicology, practical safeguards should address several questions.
Performance on a narrow historical dataset may not generalize to patients with mixed or unknown exposures.
Independent evaluation at another institution or population is more informative than repeated testing on closely related development data.
Users should be able to distinguish source-supported findings from model-generated interpretations.
Unknown dose, unknown substance and uncertain timing should remain explicit uncertainties.
Antidote doses, drug concentrations and other critical numeric outputs require reliable calculations and appropriate clinical verification.
AI-generated records, severity estimates and management suggestions should be reviewed by qualified professionals.
Data governance must address confidentiality, access, consent when required, security and applicable privacy obligations.
Models, clinical workflows and poisoning patterns can change.
Evaluation should not end when a product is launched.
Consider a study that reports an accuracy of 90%.
Before treating that number as clinically meaningful, ask:
What exactly was the model predicting?
Which substances or outcomes were included?
How were cases selected?
Did the study exclude polysubstance poisoning?
Was validation performed on independent patients?
What were the false-negative and false-positive rates?
Could an error delay a lifesaving intervention?
Did the study measure actual patient outcomes?
Was the model evaluated prospectively?
Were the results independently reproduced?
A high accuracy, F1 score or area under the receiver operating characteristic curve does not automatically demonstrate improved patient care.
Similarly, a model that performs well on documentation tasks may not perform well on diagnosis or treatment selection.
Machine learning may also help researchers analyze large volumes of poisoning reports, laboratory findings and public-health information.
Potential applications include detecting:
unusual clusters;
changes in substances reported to poison centers;
emerging patterns of co-exposure;
differences in exposure trends across regions.
But statistical signals are not confirmed outbreaks.
A meaningful signal requires investigation and, when appropriate, clinical, laboratory or public-health confirmation.
For an example of how MedicalToxic has reported emerging research while highlighting AI safety, see New Poisoning Research Points to Faster ED Triage, Methanol Mortality Markers and Safer AI Use in Toxicology.
AI performance depends on the task.
A model that classifies a limited set of poisons may perform poorly when the number of possible substances expands.
A large dataset does not guarantee bedside reliability.
Dataset selection, missing information and external validity matter.
Better documentation scores do not guarantee safer clinical decisions.
The 2026 acute-poisoning study identified potentially serious errors in AI-generated notes.
An AI prediction is not a confirmed diagnosis.
Clinical findings and validated testing remain essential.
AI confidence is not evidence strength.
Plausible or assertive language can conceal uncertainty.
Automated calculations and generative explanations should be evaluated separately.
Critical numeric decisions require reliable input, computation and review.
Human oversight is not optional in high-stakes care.
AI may assist toxicologists, but current evidence does not justify replacing professional judgment.
Some models can rank possible substances using symptoms and exposure data. Accuracy depends on the substances included, the dataset and the clinical circumstances. Such predictions require confirmation.
There is no general evidence supporting that conclusion. Some models outperformed selected physician comparators on specific datasets, but this does not establish superiority across real clinical practice.
Researchers have developed models for outcomes such as intubation or intensive care needs. Most published evidence does not yet establish that deploying these models improves patient outcomes.
It may help with structured documentation, information retrieval, workflow support and research. Clinical effectiveness and safety must be validated for each intended use.
A generative AI recommendation should not be accepted without verification against authoritative clinical guidance and patient-specific information. High-risk calculations require appropriate safeguards.
One major risk is false confidence: an incorrect answer may appear persuasive, particularly when exposure information is incomplete or the patient falls outside the model's tested population.
Artificial intelligence is an important research and development opportunity for medical toxicology.
Direct studies show potential for identifying patterns in poisoning records, predicting selected outcomes and supporting clinical documentation.
But those same studies reveal important limitations.
Performance can decline when classification becomes more complex. Retrospective predictive models have not necessarily demonstrated better patient outcomes. Language models may generate clinically significant errors even when their overall documentation appears strong.
The most defensible current approach is to use AI as reviewable clinical support, with validated calculations, transparent evidence, clear uncertainty and qualified professional oversight.
AI should help clinicians make better-informed decisions—not create the impression that difficult toxicology decisions have become automatic.
© All copyright of this material is absolute to Medical toxicology
Dr. Omid Mehrpour (MD, FACMT) is a senior medical toxicologist and physician-scientist with over 15 years of clinical and academic experience in emergency medicine and toxicology. He founded Medical Toxicology LLC in Arizona and created several AI-powered tools designed to advance poisoning diagnosis, clinical decision-making, and public health education. Dr. Mehrpour has authored over 250 peer-reviewed publications and is ranked among the top 2% of scientists worldwide. He serves as an associate editor for several leading toxicology journals and holds multiple U.S. patents for AI-based diagnostic systems in toxicology. His work brings together cutting-edge research, digital innovation, and global health advocacy to transform the future of medical toxicology.
Keep reading